The trademark EPAROXAN was filed by SCIENCEPHARMA spółka z ograniczoną odpowiedzialnością, a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on April 26, 2016, and received one opposition filed on July 25, 2016 by HEXAL AKTIENGESELLSCHAFT on Likelihood of confusion. the opponent was represented by BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB - PATENTANWÄLTE RECHTSANWÄLTE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 25, 2016
The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes, including anticoagulants
Medicines for medical purposes
Biological preparations for medical use
Biological tissue cultures for medical purposes
Chemical preparations for medical purposes
Chemical preparations for pharmaceutical purposes
Chemico-pharmaceutical preparations
Dietetic foods adapted for medical use
Dietetic beverages adapted for medical purposes
Pharmaceutical preparations
Blood for medical purposes
Acids for pharmaceutical purposes
Lozenges for pharmaceutical purposes
Vitamin preparations
Infant formula
Lozenges for pharmaceutical purposes
Dietary supplements, included in this class
Medical products, included in this class.
The mark was filed in class 35 with following description of goods:
Advertising
Marketing
Dissemination of advertising matter in paper form and in electronic format
On-line advertising on a computer network
Publicity columns preparation
Radio advertising
Advertising by mail order
Television advertising
Dissemination of advertisements
Updating of advertising material
Marketing research
Marketing studies
Display and presentation of products for others.
The mark was filed in class 42 with following description of goods: